Carlota García

Dr. Carlota García


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2020 in The Clinical Respiratory Journal
Verified
Journal Article
Open access
PDF file
CGCarlota García
Carlota García
ESTHER BARREIROESTHER BARREIRO
ESTHER BARREIRO
XMXavier Muñoz
Xavier Muñoz
VBVictor Bustamante‐Madariaga
Victor Bustamante‐Madariaga
IDIgnacio De‐Granda‐Orive
Ignacio De‐Granda‐Orive
Francisco-Javier Gonzalez-BarcalaFrancisco-Javier Gonzalez-Barcala
Francisco-Javier Gonzalez-Barcala
Objective: Inhalation therapy is one of the key pillars in the treatment of chronic obstructive diseases, such as asthma and COPD (Chronic obstructive pulmonary disease); however, wide number of errors occur with high frequency in the inhalation manoeuvres among these patient. This review discuss the main errors made with inhalation devices, factors associated with poor IT (inhalation technique), their consequences and possible solutions.Data sources: To do this, we performed a search of any publications available in PubMed between the years 2000 and 2019, using the key words: asthma, COPD, obstructive lung disease, inhalers, misuse and errors.Study selections: After a review of the titles and abstracts by the working group, the articles chosen were considered the most relevant in providing evidence of the problems and establishing solutions in the inhalation treatment of asthma and COPD.Results: There are several publications that associated the errors in the inhalation technique with a poor prognosis both of asthma and COPD. Most authors generally agree in that a poor IT is associated with poor control of the symptoms.Conclusions: It is essential to review the IT in all our patients with asthma and COPD due to the high socio‐economic impact that it involves; an effort must be made to homogenise the evaluation of IT, so that it helps to transmit a clear message to the patients, as well as to the health professionals on what is and what is not a correct manoeuvre.

19 May 2023 in Respiratory Medicine
Verified
Journal Article
Open access
CGCarlota García
Carlota García
Alberto Ruano-RavinaAlberto Ruano-Ravina
Alberto Ruano-Ravina
MPMonica Pérez-Ríos
Monica Pérez-Ríos
LGLucía Martín Gisbert
Lucía Martín Gisbert
Maria Leonor Varela LemaMaria Leonor Varela Lema
Maria Leonor Varela Lema
AAAlvar Agustí
Alvar Agustí
Chronic Obstructive Pulmonary Disease (COPD) is the third cause of death worldwide. While tobacco smoking is a key risk factor, COPD also occurs in never-smokers (NS). However, available evidence on risk factors, clinical characteristics, and natural history of the disease in NS is scarce. Here, we perform a systematic review of the literature to better describe the characteristics of COPD in NS. We searched different databases following the PRISMA guidelines with explicit inclusion and exclusion criteria. A purpose-designed quality scale was applied to the studies included in the analysis. It was not possible to pool the results due to the high heterogeneity of the studies included. A total of 17 studies that met the selection criteria were included, albeit only 2 of them studied NS exclusively. The total number of participants in these studies were 57,146 subjects, 25,047 of whom were NS and 2,655 of the latter had NS-COPD. Compared to COPD in smokers, COPD in NS is more frequent in women and older ages, and is associated with a slightly higher prevalence of comorbidities. There are not enough studies to understand if COPD progression and clinical symptoms in NS are different to that of ever-smokers. There is a significant knowledge gap on COPD in NS. Given that COPD in NS account for about a third of all COPD patients in the world, particularly in low-middle income countries, and the decrease in tobacco consumption in high income countries, understanding COPD in NS constitutes a public-health priority.

14 January 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Francisco-Javier Gonzalez-BarcalaFrancisco-Javier Gonzalez-Barcala
Francisco-Javier Gonzalez-Barcala
JNJUAN JOSÉ NIETO-FONTARIGO
JUAN JOSÉ NIETO-FONTARIGO
TLTamara Lourido-Cebreiro
Tamara Lourido-Cebreiro
CGCarlota García
Carlota García
MSMaria-Esther San-Jose
Maria-Esther San-Jose
FSFrancisco J. Salgado
Francisco J. Salgado
The relationship between obesity and asthma exacerbations is still under debate. The aim of our work is to analyse the relationship between obesity and hospital re-admissions in asthmatics. A review was retrospectively performed on all hospital admissions of adult patients due to asthma exacerbation occurring in our hospital for 11 years. All those cases with asthma as the first diagnosis in the discharge report were included, or those with asthma as the second diagnosis provided when the first diagnosis was respiratory infection or respiratory failure. Only the first hospital admission of each patient was included in this study. The Odds Ratios of a higher incidence of early/late readmissions due to asthma exacerbation were calculated using a binary logistic regression, using the body mass index (BMI) as independent variable, adjusted for all the variables included in the study. The study included 809 patients with a mean age of 55.6 years, and 65.2% were female. The majority (71.4%) were obese or overweight. No significant relationship was observed in the univariate or multivariate analyses between overweight or obesity and the early or late hospital readmissions due to asthma. Therefore, obesity does not seem to be a determining factor in the risk of asthma exacerbations.

1 January 2024 in Respiratory Medicine
Verified
Journal Article
Closed access
JÁJosé M. Álvarez-Dobaño
José M. Álvarez-Dobaño
CGCarlota García
Carlota García
GAGerardo Atienza
Gerardo Atienza
MNMaria Elena Toubes Navarro
Maria Elena Toubes Navarro
NRNuria Rodríguez-Núñez
Nuria Rodríguez-Núñez
LVLuis G. Valdés
Luis G. Valdés

19 February 2026 in Respiratory Medicine
Verified
Journal Article
Open access
MRMyriam Calle Rubio
Myriam Calle Rubio
JSJuan José Soler-Cataluña
Juan José Soler-Cataluña
JCJosé Luis López Campos
José Luis López Campos
BABernardino Alcazar
Bernardino Alcazar
FGFrancisco Javier Callejas González
Francisco Javier Callejas González
MMMarc Miravitlles
Marc Miravitlles
Preventing exacerbations in chronic obstructive pulmonary disease (COPD) is a priority, as exacerbations accelerate progression, increase mortality, and impair quality of life. The use of biologics that act on specific inflammatory pathways through monoclonal antibodies in COPD offers a precision medicine strategy for high-risk patients who continue to experience frequent exacerbations despite optimal inhaled treatment. However, the use of these biologic therapies in COPD presents significant challenges, stemming from the clinical heterogeneity of the disease and the limited evidence available. Their indication and management must be personalized and precise, raising questions about how to implement a biologic therapy strategy in COPD in clinical practice. This clinical protocol focused on the use of biologic therapy in COPD sets out the objectives ("Why"), describes the selection of candidates ("In which patients"), the monitoring of response ("What should be measured") and how to implement it in clinical practice ("How") based on the available evidence and expert consensus.

22 October 2026 in Tobacco Induced Diseases
Verified
Journal Article
Open access
CRCarlos Rábade-Castedo
Carlos Rábade-Castedo
CGCarlota García
Carlota García
PLPaula Lado-Argibay
Paula Lado-Argibay
GFGoretti Fernández-Morón
Goretti Fernández-Morón
PVPatricia Susana Vázquez-Millán
Patricia Susana Vázquez-Millán
LVLuis Valdés-Cuadrado
Luis Valdés-Cuadrado
Introduction: Chronic obstructive pulmonary disease (COPD) is the third leading cause of morbidity and mortality, making early detection crucial to improving prognosis. This study aimed to identify new cases of COPD, clinical profiles, and predictors among smokers and their cohabiting family...